BiVictriX Therapeutics Plc (BVX.L)
GBp 10.0
(17.65%)
GBp 10.0
(17.65%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 758 Thousand GBP | 30.92% |
| 2022 | 579 Thousand GBP | 4.51% |
| 2021 | 554 Thousand GBP | 67.88% |
| 2020 | 330 Thousand GBP | 283.72% |
| 2019 | 86 Thousand GBP | 126.32% |
| 2018 | 38 Thousand GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 676 Thousand GBP | -10.82% |
| 2023 Q2 | 625 Thousand GBP | 7.94% |
| 2023 Q4 | 758 Thousand GBP | 21.28% |
| 2023 FY | 758 Thousand GBP | 30.92% |
| 2022 Q2 | 700 Thousand GBP | 26.35% |
| 2022 FY | 579 Thousand GBP | 4.51% |
| 2022 Q4 | 579 Thousand GBP | -17.29% |
| 2021 Q4 | 554 Thousand GBP | -45.04% |
| 2021 Q2 | 1 Million GBP | 205.45% |
| 2021 FY | 554 Thousand GBP | 67.88% |
| 2020 Q4 | 330 Thousand GBP | 168.29% |
| 2020 FY | 330 Thousand GBP | 283.72% |
| 2020 Q2 | 123 Thousand GBP | 0.0% |
| 2019 FY | 86 Thousand GBP | 126.32% |
| 2018 FY | 38 Thousand GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|